Assyro AI

Orange Book product · Brand (NDA)

TEFLARO

CEFTAROLINE FOSAMIL

Brand (NDA)NDA 200327TE APRX ABBVIE

At a glance

Oct 29, 2010

Approved

Brand (NDA)

Application

AP

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 29, 2010

    15 yr 10 mo ago

  2. Today

  3. Patent 9629861 expires

    Listed drug product patent expiration.

    Sep 21, 2030

    in 4 yr 4 mo

  4. Patent 8247400 expires

    Listed drug product patent expiration.

    Feb 10, 2031

    in 4 yr 9 mo

Pharmaceutical detail

Active ingredient

CEFTAROLINE FOSAMIL

Strength

400MG/VIAL

Dosage form

POWDER

Route

INTRAVENOUS

TE code

AP

Application

NDA 200327

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9629861Sep 21, 2030in 4 yr 4 mo
Product
8247400Feb 10, 2031in 4 yr 9 mo
ProductU-282
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.